Caris Biorepository Research Protocol
Caris Science, Inc. · NCT01499394
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 100000
- US sites recruiting
- 38
- Study start
- November 2010
- Record last updated
- January 21, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients.
The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
Conditions: Cancer; Early Detection of Cancer; Minimal Residual Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years of age or older
- Capacity to provide informed consent
Exclusion Criteria
- Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients will not be approached for participation in the Caris Biorepository.
- Minor subjects will not be included in the Caris Biorepository, as it is possible biospecimens and data may be stored beyond the time limitations of assent and it may be impracticable to re-consent these subjects once they become adults.
- Individuals who lack the capacity to give informed consent
Recruiting US locations
University of South Alabama
Site contact: Tiffany Fulford · 251-445-3276 · tnfulford@health.southalabama.edu
Southwest Medical Imaging
Site contact: Emily Crampton · 480-425-4055 · ECrampton@esmil.com
St. Bernards Medical Center
Site contact: Dashae King · 870-207-8157 · dlking@sbrmc.org
CARTI Cancer Center
Site contact: Jesse Byrd · 501-561-2205 · Jesse.Byrd@Carti.com
ObjectiveHealth - ARcare Center for Clinical Research
Site contact: Cynthia Whitcomb · 501-214-0372 · Cynthia.Whitcomb@objective.health
Lee Memorial Health System
Site contact: Juliana Turner · 239-343-9660 · juliana.turner@leehealth.org
Cancer Care of North Florida
Site contact: Natalie Espenship · 386-755-1655 · Natalie.Espenship@cancercareofnorthflorida.com
Advent Health
Site contact: Corina Mattix · 407-303-1327 · Corina.Mattix@AdventHealth.com
The University of South Florida
Site contact: Brittney Short · 727-612-4026 · bborresen@tgh.org
Cleveland Clinic Florida
Site contact: Brianna Hammond · 954-487-2257 · HAMMONB7@ccf.org
Phoebe Putney Memorial Hospital
Albany, GA 31701
Site contact: Cathy Shoemaker, OCN CBCN · 229-312-0354
Emory University
Site contact: Sharon Egbue-Ojirogbe · 404-778-8027 · cegbueo@emory.edu
Augusta University Research Institute
Site contact: Alexander Ward · 706-721-1623 · ALWARD@augusta.edu
Cancer Center of Middle Georgia
Site contact: Audrey Bryan · 478-272-8266 · research@ccmgeorgia.com
Hope and Healing Cancer Services
Site contact: Ava Baftirovska · 630 560 0121 · abaftirovska@hopenheal.care
CHRISTUS - St. Frances Cabrini Hospital
Site contact: Crystal Dubois · 318-528-5137 · crystal.dubois2@christushealth.org
Tulane University
Site contact: Priya Bhandari · 504-988-6053 · pbhandari@tulane.edu
CHRISTUS - Highland Medical Center
Site contact: Thea Spencer · 318-681-6007 · thea.spencer@christushealth.org
Mercy Medical Center
Site contact: Rhiannon Kim · 410-951-7908 · rkim1@mdmercy.com
Sinai Hospital of Baltimore
Site contact: Pamela Nickoles · 410-601-6120 · Pnickole@lifebridgehealth.org
Hattiesburg Clinic
Site contact: Gloria Simmons · 601-288-2494 · Gloria.Simmons@forrestgeneral.com
Jackson Oncology Associates
Site contact: Teresa Davis · 601-974-5547 · tdavis@jacksononcology.com
University of Mississippi Medical Center
Site contact: Tanya Robinson · 601-815-2123 · trobinson13@umc.edu
ObjectiveHealth - Premier Health Research
Site contact: Lori Walsh · 862-294-0418 · Lori.Walsh@objective.health
CHRISTUS - St. Vincent Regional Cancer Center
Site contact: MiQuela Gutierrez · 505-913-8822 · Miquela.Gutierrez@stvin.org
St. Lawrence Health System
Site contact: McKenna Boula · 315-261-6319 · McKenna.Boula@rochesterregional.org
National Translational Research Group
Site contact: Stella Smaragdas · 631-675-5103 · ssmaragdas@nycancer.com
Altru Health System
Site contact: Alexis Tatum · 701-780-1563 · ATATUM@altru.org
NEO Urology Associates
Site contact: Tina Picino · 330-729-9214 · tpicino@neourology.com
Great Lakes Medical Research
Site contact: Cortney Vazquez · 216-372-0505 · cvazquez@thectnx.com
Bend Memorial Clinic
Site contact: Madison Cox · 541-706-5339 · mklinskicox@summithealth.com
Clinical Biotechnology Research Institute at RSFH
Site contact: Aindrea Maddray · 843-724-2204 · Aindrea.Maddray@rsfh.com
Spartanburg Regional Health Services
Site contact: Kamara Mertz-Rivera · 864-560-6104 · kmertz-Rivera@gibbscc.org
West Cancer Center
Site contact: Melissa Smith · 901-683-0055 · msmith@WESTCLINIC.com
ObjectiveHealth - Amarillo Premier Research
Site contact: Lauren Kuehler · 806-641-0256 · Lauren.Kuehler@objective.health
CHRISTUS - St. Michael's Health
Site contact: Kimberly Everett · 903-614-6885 · kimberly.everett@christushealth.org
CAMC Clinical Trials
Charleston, WV 25304
Site contact: Kristi Sutphin · 304-388-9945 · kristi.sutphin@CAMC.org
Mercy Health
Site contact: Ashli Huppert · 608-756-6695 · ahuppert@mhemail.org
Study contacts (from the official record)
- Mary Baker · carisresearch@carisls.com
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65